REQUEST A DEMO
Total
USD $0.00
Search more companies

Clematis Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Clematis Pharma Kft. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Clematis Pharma Kft. is a company in Hungary, with a head office in Budapest. It operates in the Pharmacies and Drug Stores industry. It was first established on December 18, 2007. It currently has a total number of 9 (2023) employees. From the latest financial highlights, Clematis Pharma Kft. reported a net sales revenue increase of 7.47% in 2022. A growth of 23.49% was recorded in its total assets. In 2022, Clematis Pharma Kft.’s net profit margin increased by 2.58%.

Headquarters
Peceli ut 188.
Budapest; Budapest; Postal Code: 1171

Contact Details: Purchase the Clematis Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Clematis Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Clematis Pharma Kft. report to view the information.
Registered Capital:
Purchase the Clematis Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Clematis Pharma Kft. report to view the information.
Incorporation Date:
December 18, 2007
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Clematis Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.47%
Total operating revenue
7.42%
Operating profit (EBIT)
26.47%
EBITDA
24.62%
Net Profit (Loss) for the Period
39.5%
Total assets
23.49%
Total equity
120.71%
Operating Profit Margin (ROS)
1.63%
Net Profit Margin
2.58%
Return on Equity (ROE)
-31.84%
Quick Ratio
0.28%
Cash Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?